ALKEON CAPITAL MANAGEMENT LLC Q3 2020 Filing

Filed November 16, 2020

Portfolio Value

$54.0B

Holdings

140

Report Date

Q3 2020

Filing Type

13F-HR

All Holdings (140 positions)

#StockSharesValue% PortfolioType
101
ALTREURALTAIR ENGR INC
875,000$36.7M0.07%
102
MCHPMICROCHIP TECHNOLOGY INC.
355,000$36.5M0.07%
103
PSNPARSONS CORPORATION
1,050,093$35.2M0.07%
104
SNOWSNOWFLAKE INC
140,000$35.1M0.07%
105
DCPHEURDECIPHERA PHARMACEUTICALS IN
670,975$34.4M0.06%
106
COUP 0.125 06/15/25COUPA SOFTWARE INC
13,750,000$32.6M0.06%
107
KPTIEURKARYOPHARM THERAPEUTICS INC
2,164,900$31.6M0.06%
108
ALLOVIR INC
1,097,000$30.2M0.06%
109
MERSANA THERAPEUTICS INC
1,550,000$28.9M0.05%
110
TTWOTAKE-TWO INTERACTIVE SOFTWAR
173,222$28.6M0.05%
111
ZMZOOM VIDEO COMMUNICATIONS IN
60,000$28.2M0.05%
11215,000,000$25.9M0.05%
113
RNAAVIDITY BIOSCIENCES INC
875,000$24.6M0.05%
114
AALAMERICAN AIRLS GROUP INC
2,000,000$24.6M0.05%Call
115
AMWLAMERICAN WELL CORP
800,000$23.7M0.04%
116
SPYSPDR S&P 500 ETF TR
67,425,000$22.6M0.04%Put
117
DDOGDATADOG INC
215,000$22.0M0.04%
118
AYX 0.5 08/01/24ALTERYX INC
17,000,000$20.3M0.04%
119
WBWEIBO CORP
500,000$18.2M0.03%Put
120
PMVPPMV PHARMACEUTICALS INC
475,000$16.9M0.03%
121
APLTAPPLIED THERAPEUTICS INC
738,039$15.3M0.03%
122
PROOFPOINT INC
15,000,000$14.9M0.03%
123
BEAMBEAM THERAPEUTICS INC
500,000$12.3M0.02%
124
RCUSARCUS BIOSCIENCES INC
714,845$12.3M0.02%
125
PYPLPAYPAL HLDGS INC
48,281$9.5M0.02%
126
TWILIO INC
2,500,000$8.7M0.02%
127
MPWRMONOLITHIC PWR SYS INC
30,000$8.4M0.02%
128
ORICORIC PHARMACEUTICALS INC
303,061$7.6M0.01%
129
ALTAIR ENGR INC
6,600,000$7.3M0.01%
130
CYTKCYTOKINETICS INC
300,000$6.5M0.01%
131
NDQINVESCO QQQ TR
22,900,000$6.4M0.01%Put
132
FIVE9 INC
2,000,000$6.3M0.01%
133
DNLIDENALI THERAPEUTICS INC
160,000$5.7M0.01%
134
EQREQUITY RESIDENTIAL
100,000$5.1M0.01%Put
135
MORFMORPHIC HLDG INC
150,000$4.1M0.01%
136
QTWO 0.75 06/01/26Q2 HLDGS INC
3,000,000$3.7M0.01%
137
MONGODB INC
1,000,000$3.4M0.01%
138
GDSGDS HLDGS LTD
30,000$2.5M0.00%
139
NEOLEUKIN THERAPEUTICS INC
200,000$2.4M0.00%
140
KROSKEROS THERAPEUTICS INC
30,000$1.2M0.00%
PreviousPage 2 of 2